U.S. FDA approves generic versions of Merck's Singulair

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co Inc's best-selling product.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MmCODogOE4Y/us-usa-fda-singulair-idUSBRE8721IT20120803

phlebotomy training in va phlebotomy certification in nj phlebotomy training in rockford il